Immuneering nets $62m Series B
Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing.
Immuneering, a provider of bioinformatics, has raised $62 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination